Promising Innovative Medicine

News

BI drug named Promising Innovative Medicine in mesothelioma

Boehringer Ingelheim is the latest company to gain a Promising Innovative Medicine (PIM) status in the UK for one of its drugs.

News

Immunocore’s rare cancer treatment gains UK Promising Medici...

Immunocore has gained a Promising Innovative Medicines (PIM) designation in the UK for its candidate immunotherapy for patients with metastatic uveal melanoma, a rare tumour of the eye.

News

London, UK - January 8, 2015: City of London panorama includes high street with office and governments buildings

Orchard’s gene therapy gains UK ‘promising innovative medici...

A UK biotech start-up has gained a sought after ‘promising innovative medicine’ (PIM) designation for its ultra-rare disease gene therapy.

News

Novartis drug gets 'Promising Innovative Medicine' status in...

Novartis's cancer drug Zykadia has become one of the first drugs to snag Promising Innovation Medicine status in the UK's new early access scheme.

BI drug named Promising Innovative Medicine in mesothelioma

Immunocore’s rare cancer treatment gains UK Promising Medici...

Orchard’s gene therapy gains UK ‘promising innovative medici...

Novartis drug gets 'Promising Innovative Medicine' status in...

Novo commits $200m to support World Diabetes Federation

Securing your ROI: Turning post-acquisition integration into...

Promising Innovative Medicine

Editor's Picks